Differential effects of MDMA, cocaine, and cannabis use severity on distinctive components of the executive functions in polysubstance users: A multiple regression analysis

Addictive Behaviors

Volumn 30, Issue 1, 2005, Pages 89-101

  Verdejo García, Antonio J ^a   López Torrecillas, Francisca ^a   Aguilar De Arcos, Francisco ^a   Pérez García, Miguel ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

Cannabis; Cocaine; Executive functions; MDMA; Severity; Substance abuse

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CANNABIS; COCAINE;

ADULT; ARTICLE; COGNITION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EXPOSURE; FEMALE; HUMAN; MALE; NEUROPSYCHOLOGY; SUBSTANCE ABUSE; TASK PERFORMANCE; WORKING MEMORY;

ADULT; ALCOHOLISM; COCAINE-RELATED DISORDERS; COGNITION DISORDERS; FEMALE; HUMANS; MALE; MARIJUANA ABUSE; MEMORY DISORDERS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEUROPSYCHOLOGICAL TESTS; PSYCHIATRIC STATUS RATING SCALES; REGRESSION ANALYSIS; SUBSTANCE-RELATED DISORDERS;

EID: 9244252537     PISSN: 03064603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addbeh.2004.04.015     Document Type: Article

References (36)

1. Barkley R.A. The executive functions and self-regulation: An evolutionary neuropsychological perspective. Neuropsychology Review. 11:2001;1-29
2. Bhattachary S., Powell J.H. Recreational use of 3-4- methyledioxymethanphetamine (MDMA) or "ecstasy": Evidence for cognitive impairment. Psychological Medicine. 31:2001;647-658
3. Bolla K.I., Funderburk F.R., Cadet J.L. Differential effects of cocaine and cocaine+alcohol on neurocognitive performance. Neurology. 54:2000;2285-2292
4. Bolla K.I., McCann U.D., Ricaurte G.A. Memory impairment in abstinent MDMA ("ecstasy") users. Neurology. 51:1998;1532-1537
5. Cohen Z., Bonvento G., Lacombe P., Hamel E. Serotonin in the regulation of brain microcirculation. Progress in Neurobiology. 50:1996;335-362
6. Collette F., Van der Linden M. Brain imaging of the central executive component of working memory. Neuroscience and Behavioral Reviews. 26:2002;105-125
7. Croft R.J., Mackay A.J., Mills A., Gruzelier J. The relative contributions of ecstasy and cannabis to cognitive impairment. Psychopharmacology. 153:2001;373-379
8. Fillmore M.T., Rush C.R. Impaired inhibitory control of behavior in chronic cocaine users. Drug and Alcohol Dependence. 66:2002;265-273
9. Fillmore M.T., Rush C.R., Hays L. Acute effects of oral cocaine on inhibitory control of behavior in humans. Drug and Alcohol Dependence. 67:2002;157-167
10. Fox H.C., Parrot A.C., Turner J.J.D. Ecstasy use: Cognitive deficits related to dosage rather than self-reported problematic use of the drug. Journal of Psychopharmacology. 15:2001;273-281
11. Golden, C. J. (1978). Stroop Color and Word Test. A manual for clinical and experimental uses. Wood Dale. Illinois: Stoelting Co. Spanish Adaptation by TEA Ediciones S.A. (1999), Madrid: España.
12. Goldstein R.Z., Volkow N.D. Drug addiction and its underlying neurobiological basis: Neuroimaging evidence for the involvement of the frontal cortex. American Journal of Psychiatry. 159:2002;1642-1652
13. Gouzoulis-Mayfrank E., Daumann J., Tuchtenhagen F., Pelz S., Becker S., Kunert H.K., Fimm B., Sass H. Impaired cognitive performance in drug free users of recreational ecstasy (MDMA). Journal of Neurology, Neurosurgery and Psychiatry. 68:2000;719-725
14. Heaton R.K., Grant I., Mathews C.G. Comprehensive norms for an expanded Halstead-Reitan Battery: Demographic corrections, research findings, and clinical applications. 1991;Psychological Assessment Resources, Odessa, FL
15. Kish S.J. How strong is the evidence that brain serotonin neurons are damaged in human users of ecstasy? Pharmacology, Biochemistry and Behavior. 71:2002;845-855
16. Lezak M.D. Neuropsychological assessment. 3rd ed.:1995;Oxford University Press, New York
17. López-Torrecillas F., Godoy J.F., Pérez-García M., Godoy D., Sánchez-Barrera M. Variables modulating stress and coping that discriminate drug consumers from low or not drug consumers. Addictive Behaviors. 25:2001;161-165
18. Lyvers M., Yakimoff M. Neuropsychological correlates of opioid dependence and withdrawal. Addictive Behaviors. 28:2003;605-611
19. Mintzer M.Z., Stitzer M.L. Cognitive impairment in methadone maintenance patients. Drug and Alcohol Dependence. 67:2002;41-51
20. Miyake A., Friedman N.P., Emerson M.J., Witzky A.H., Howerther A. The unity and diversity of executive function and their contribution to complex frontal lobe tasks: A latent variable analysis. Cognitive Psychology. 41:2000;49-100
21. Nixon S.J. Neurocognitive performance in alcoholics: Is polysubstance abuse important? American Psychological Society. 10:1999;181-185
22. Obrocky J., Schmoldt A., Buchert R., Andresen B., Petersen K., Thomasius R. Specific neurotoxicity of chronic use of ecstasy. Toxicology Letters. 127:2002;285-297
23. Ornstein T.J., Iddon J.L., Baldacchino A.M., Sahakian B.J., London M., Everitt B.J., Robbins T.W. Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers. Neuropsychopharmacology. 23:2000;113-126
24. Pau W.H., Lee M.C., Chan S.F. The impact of heroin on frontal executive functions. Archives of Clinical Neuropsychology. 17:2002;663-670
25. Peterson B.S., Skudlarsky P., Chris Gatenby J., Zhang H., Anderson A.W., Gore J.C. An fMRI study of Stroop Word-Color Interference: Evidence for cingulate subregions subserving multiple distributed attentional systems. Biological Psychiatry. 45:1999;1237-1258
26. Roberts A.C., Robbins T.W., Weiskrantz L. The prefrontal cortex: Executive and cognitive functions. 1998;Oxford University Press, New York
27. Rogers R.D., Robbins T.W. Investigating the neurocognitive deficits associated with chronic drug misuse. Current Opinion in Neurobiology. 11:2001;250-257
28. Roselli M., Ardila A. Cognitive effects of cocaine and polydrug abuse. Journal of Clinical and Experimental Neuropsychology. 18:1996;122-135
29. Ruff C.C., Knauff M., Fangmeier T., Spreer J. Reasoning and working memory: Common and distinct neuronal processes. Neuropsychologia. 41:2003;1241-1253
30. Seisdedos N. Cambios: Test de flexibilidad cognitiva. 1994;TEA Ediciones, Madrid
31. Semple D.M., Ebmeier K.P., Glubus M.F., O'Carroll R.F., Johnsione F.C. Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ("ecstasy") users. British Journal of Psychiatry. 175:1999;63-69
32. Solowij N. Cannabis and cognitive functioning. 1998;Cambridge University Press, New York
33. Verheul R. Co-morbidity of personality disorders in individuals with substance use disorders. European Psychiatry. 16:2001;274-282
34. Volkow N.D., Fowler J.S. Addiction: A disease of compulsion and drive: Involvement of the orbitofrontal cortex. Cerebral Cortex. 10:2000;318-325
35. Wareing M., Fisk J.E., Murphy P.N. Working memory deficits in current and previous users of MDMA ("ecstasy"). British Journal of Psychology. 91:2000;181-188
36. Wechsler, D. (1997). Wechsler Adult Intelligence Scale 3rd ed. San Antonio, TX: The Psychological Corporation. Spanish Adaptation by TEA Ediciones S.A. (1999), Madrid: España.